← All cohorts · West Nile virus cohorts

Sejvar West Nile Neuroinvasive Disease Cohort

source record (JSON) · schema v2.0.0 · CC BY 4.0

Design notes & limitations. Small prospective inception cohort of confirmed neuroinvasive disease with structured serial assessment to 90 days. Short follow-up and no control group; captures acute-to-subacute neurological recovery.

Identity & trigger

Cohort id
sejvar-wnv-neuroinvasive
Aliases
WNV neuroinvasive prospective cohort
Outbreak / event
n/r
Pathogen
West Nile virus (Virus)
Exposure ascertainment
serology

Design

Design
Prospective (inception)
Denominator defined
Yes
Denominator method
Patients with West Nile virus neuroinvasive disease confirmed by CSF IgM, enrolled during acute illness.
Recruitment
hospital
Time zero
Acute West Nile neuroinvasive disease presentation (week)
Control group
None

Size & attrition

Enrolled
55
Analysed / enrolled
55/55 (100%)
Max follow-up (months)
3

Biospecimens

Specimens
Yes
Types
serum, csf
Acute-phase specimens
Yes
Biobank
Unknown
External access
Unknown

Observations (1)

Functional outcomes

49% Proportion

Measure
Any persistent symptom func:any-persistent-symptom
As worded
“limb weakness at initial clinical presentation”
Population
whole cohort · denominator Assessed at timepoint · N=n=55
Timing
0 mo (Acute) · ref Not reported
Method
Unclear
Comparator
no comparator
Comparability signature
8782bfb51f — measure func:any-persistent-symptom · Unclear · ref Not reported · denom Assessed at timepoint · Acute · Proportion
Provenance
Results (49% weakness, 35% tremor, 16% cranial neuropathy at presentation) · Manual · verified OSMF research-tracker (web-verified against source) on 2026-07-20

Publications

Provenance & verification

Registration
NCT00138463
Funders
National Institutes of Health (USA)
Related cohorts
none
Symptom-inventory scope
Targeted panel
Last verified
2026-07-20 — OSMF research-tracker (web-verified against source)